Effect of berberine on catecholamine levels in rats with experimental cardiac hypertrophy

Life Sciences

Volumn 72, Issue 22, 2003, Pages 2499-2507

  Hong, Ying ^a,b   Hui, Sarah S C ^a   Chan, Benjamin T Y ^a   Hou, Jiayu ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Berberine; Captopril; Cardiac hypertrophy; Catecholamine

Indexed keywords

ADRENALIN; BERBERINE; CAPTOPRIL; CATECHOLAMINE; NORADRENALIN;

ABDOMINAL AORTA; ADRENALIN BLOOD LEVEL; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; CATECHOLAMINE DEPLETION; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL MODEL; HEART SURGERY; HEART VENTRICLE; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; RAT; SYMPATHETIC TONE;

EID: 0037453202     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00144-9     Document Type: Article

References (19)

1. Sugden P.H., Clerk A. Cellular mechanisms of cardiac hypertrophy. J. Mol. Med. 76:1998;725-746.
2. Sprenkle A.B., Murray S.F., Glembotski C.C. Involvement of multiple cis elements in basal-and α-adrenergic agonist-inducible atrial natriuretic factor transcription. Circ. Res. 77:1995;1060-1069.
3. Bhambi B., Eghbali M. Effect of norepinephrine on myocardial collagen gene expression and response of cardiac fibroblasts after norepinephrine treatment. Am. J. Pathol. 139:1991;1131-1142.
4. Morgan H.E., Baker K.M. Cardiac hypertrophy. Circulation. 83:1991;13-25.
5. Biohopric N.H., Kedes L. Adrenergic regulation of the skeletal α-actin gene promoter during myocardial cell hypertrophy. Proc. Natl. Acad. Sci. 88(3):1991;2132-2136.
6. Swedberg K., Eneroth P., Kjekshus J., Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation. 82:1990;1730-1736.
7. Steinberg S.F. The cellular actions of β-adrenergic receptor agonists, looking beyond cAMP. Circ. Res. 87:2000;1079-1082.
8. Jalil A., Horiuchi M., Nomoato M., Kobayashi K., Saheki T. Catecholamine metabolism inhibitors and receptor blockades only partially suppress cardiac hypertrophy of juvenile visceral steatosis mice with systemic carnitine deficiency. Life Sciences. 64:1999;1137-1144.
9. Schnabel P., Böhm M. Sympathetic activation in heart failure: a target of therapeutic approaches. Z. Kardiol. 88(Suppl. 3):1999;5-11.
10. Hong Y., Hui S.C., Chan T.Y., Hou J.Y. Effect of berberine on regression of pressure-overload induced cardiac hypertrophy in rats. Am. J. Chin. Med. 30(4):2002;1-11.
11. Schunkert H., Weinberg E.O., Bruckschlegel B., Riegger A.J.G., Lorell B.H. Alteration of growth responses in established cardiac pressure overload hypertrophy in rats with aortic banding. J. Clin. Invest. 96:1995;2768-2774.
12. Kawai H., Mohan A., Hagen J., Dong E., Armstrong J., Stevens S.Y., Liang C.S. Alterations in cardiac adrenergic terminal function and β-adrenoceptor density in pacing-induced heart failure. Am. J. Physiol. Heart. Circ. Physiol. 278:2000;H1708-H1716.
13. Hasking G.J., Jennings G.L., Johns J.A., Korner P.I. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 73:1986;615-621.
14. Eisenhofer G., Friberg P., Rundqvist B., Quyyumi A.A., Lambert G., Kaye D.M., Kopin I.J., Goldstein D.S., Esler M.D. Cardiac sympathetic nerve function in congestive heart feilure. Circulation. 93:1996;1667-1676.
15. Chidsey C.A., Braunwald E., Morrow A.G., Mason D.T. Myocardial norepinephrine concentration in man. Effects of reserpine and of congestive heart failure. N. Engl. J. Med. 269:1963;653-658.
16. Patel K.P., Zhang K., Carmines P.K. Norepinephrine turnover in peripheral tissues of rats with heart failure. Am. J. Physiol. Regul. Integ. Comp. Physiol. 278:2000;R556-R562.
17. Emilien G., Maloteaux J.M. Current therapeutic uses and potential of β-adrenoceptor agonists and antagonists. Eur. J. Clin. Pharmacol. 53:1998;389-404.
18. Ungerer M., Böhm M., Elce J.S., Erdmann E., Lohse M.J. Altered expression of β-adrenergic receptors in the failing human heart. Circulation. 87:1993;454-463.
19. Kawai H., Fan T.H.M., Dong E., Siddiqui R.A., Yatani A., Stevens S.Y., Liang C.S. ACE inhibition improves cardiac NE uptake and attenuates sympathetic nerve terminal abnormalities in heart failure. Am. J. Physiol. 277:1999;H1609-H1617. [Heart Circ. Physiol. 46].